Silence Therapeutics plc
SLNCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $49,438 | -$27,354 | -$28,530 | $22,891 |
| Dep. & Amort. | -$286 | $148 | $138 | $119 |
| Deferred Tax | -$10 | $10 | $0 | $0 |
| Stock-Based Comp. | -$4,825 | $2,085 | $3,540 | $3,423 |
| Change in WC | -$2,245 | -$4,502 | $10,492 | -$26,324 |
| Other Non-Cash | -$52,752 | $7,829 | $2,051 | -$24,974 |
| Operating Cash Flow | -$10,891 | -$21,784 | -$12,309 | -$24,864 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $52 | -$48 | -$4 | -$56 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $72,449 | -$2,389 | -$70,060 | -$21,262 |
| Inv. Sales/Matur. | -$875 | $875 | $25,683 | $91,431 |
| Other Inv. Act. | -$18,531 | $0 | $0 | -$1,985 |
| Investing Cash Flow | $53,095 | -$1,562 | -$44,381 | $68,129 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $49 |
| Stock Issued | -$15 | $1 | $14 | -$17,684 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $9,336 |
| Financing Cash Flow | -$0 | $1 | $14 | -$8,299 |
| Forex Effect | -$2,323 | $198 | $232 | $6,930 |
| Net Chg. in Cash | $40,092 | -$23,147 | -$56,444 | $38,424 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,739 | $64,886 | $121,330 | $82,906 |
| End Cash | $81,906 | $41,739 | $64,886 | $121,330 |
| Free Cash Flow | -$10,839 | -$21,832 | -$12,313 | -$24,920 |